Safety profile of enfortumab vedotin plus pembrolizumab in locally advanced or metastatic urothelial carcinoma: a multicenter Japanese cohort studyKosuke Iwatani, Takahiro Kimura, Keiichiro Mori et al.|Japanese Journal of Clinical Oncology|2025Cited by 4